**Company Profile: Bristol-Myers Squibb - A Leading Player in the Pharmaceuticals Industry**

In the latest Fortune 2024 ranking, Bristol-Myers Squibb (BMY) secured the 98th position, a slight drop from its previous year's standing. The decline in ranking by 3 positions is a notable change for the company, indicating a competitive landscape within the industry.

As a prominent player in the health care sector, specifically in the pharmaceuticals industry, Bristol-Myers Squibb has demonstrated its commitment to innovation and growth. With a market value of $109,911.1 million as of March 28, 2024, the company continues to be a significant player in the global market. The updated market value as of July 15, 2024, stands at $81,388 million, indicating fluctuations in the market.

Bristol-Myers Squibb is a profitable company, with revenues of $45,006 million in the latest reported year. Although the revenue percent change shows a decline of 2.5%, the company's profits have seen a significant increase of 26.8%, reaching $8,025 million. This growth in profits is a testament to the company's ability to manage its operations efficiently.

The company's asset base is substantial, with total assets of $95,159 million, reflecting its strong financial position. Bristol-Myers Squibb's employee base consists of 34,100 people, highlighting the company's significant presence in the industry.

Under the leadership of CEO Christopher S. Boerner, Bristol-Myers Squibb continues to navigate the complex pharmaceuticals landscape. The company's headquarters is located in Princeton, New Jersey, and it operates as a public entity, listed on the stock exchange. Bristol-Myers Squibb's commitment to excellence is evident in its recognition as part of the Global 500 and the World's Most Admired Companies.

Despite the decline in ranking, Bristol-Myers Squibb remains a major player in the pharmaceuticals industry, with a strong focus on innovation and growth. The company's financial performance and industry recognition position it well for future success.